374 related articles for article (PubMed ID: 33333013)
21. Invasive Group A Streptococcal Infections: Benefit of Clindamycin, Intravenous Immunoglobulins and Secondary Prophylaxis.
Laho D; Blumental S; Botteaux A; Smeesters PR
Front Pediatr; 2021; 9():697938. PubMed ID: 34490159
[No Abstract] [Full Text] [Related]
22. Invasive Group A streptococcal disease in Ireland, 2004 to 2010.
Martin J; Murchan S; O'Flanagan D; Fitzpatrick F
Euro Surveill; 2011 Oct; 16(41):. PubMed ID: 22008200
[TBL] [Abstract][Full Text] [Related]
23. Oral β-Lactam Antibiotics vs Fluoroquinolones or Trimethoprim-Sulfamethoxazole for Definitive Treatment of Enterobacterales Bacteremia From a Urine Source.
Sutton JD; Stevens VW; Chang NN; Khader K; Timbrook TT; Spivak ES
JAMA Netw Open; 2020 Oct; 3(10):e2020166. PubMed ID: 33030555
[TBL] [Abstract][Full Text] [Related]
24. Clindamycin but not Intravenous Immunoglobulins reduces mortality in a retrospective cohort of critically ill patients with bacteremic Group A Streptococcal infections.
Fernández-Galilea A; Estella A; García-Garmendia JL; Loza A; Palacios-García I; Sierra-Camerino R; Seller G; Rodríguez-Delgado M; Rodriguez-Higueras I; Garnacho-Montero J
Rev Esp Quimioter; 2022 Oct; 35(5):475-481. PubMed ID: 35796693
[TBL] [Abstract][Full Text] [Related]
25. Case Report: Therapeutic Strategy With Delayed Debridement for Culture-Negative Invasive Group A Streptococcal Infections Diagnosed by Metagenomic Next-Generation Sequencing.
He W; Wu C; Zhong Y; Li J; Wang G; Yu B; Xu P; Xiao Y; Tang T
Front Public Health; 2022; 10():899077. PubMed ID: 35646803
[TBL] [Abstract][Full Text] [Related]
26. Highly virulent M1 Streptococcus pyogenes isolates resistant to clindamycin.
Plainvert C; Martin C; Loubinoux J; Touak G; Dmytruk N; Collobert G; Fouet A; Ploy MC; Poyart C
Med Mal Infect; 2015; 45(11-12):470-4. PubMed ID: 26602794
[TBL] [Abstract][Full Text] [Related]
27. Severe group A streptococcal infections in mothers and their newborns in London and the South East, 2010-2016: assessment of risk and audit of public health management.
Leonard A; Wright A; Saavedra-Campos M; Lamagni T; Cordery R; Nicholls M; Domoney C; Sriskandan S; Balasegaram S
BJOG; 2019 Jan; 126(1):44-53. PubMed ID: 30070056
[TBL] [Abstract][Full Text] [Related]
28. A multi-center clinical investigation on invasive Streptococcus pyogenes infection in China, 2010-2017.
Hua CZ; Yu H; Xu HM; Yang LH; Lin AW; Lyu Q; Lu HP; Xu ZW; Gao W; Chen XJ; Wang CQ; Jing CM
BMC Pediatr; 2019 Jun; 19(1):181. PubMed ID: 31167650
[TBL] [Abstract][Full Text] [Related]
29. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years.
Mahakit P; Vicente JG; Butt DI; Angeli G; Bansal S; Zambrano D
Clin Ther; 2006 Jan; 28(1):99-109. PubMed ID: 16490583
[TBL] [Abstract][Full Text] [Related]
30. Clindamycin in the treatment of streptococcal and staphylococcal toxic shock syndromes.
Russell NE; Pachorek RE
Ann Pharmacother; 2000; 34(7-8):936-9. PubMed ID: 10928407
[TBL] [Abstract][Full Text] [Related]
31. [Streptococcus pyogenes an emerging pathogen].
Cohen R; Aujard Y; Bidet P; Bourrillon A; Bingen E; Foucaud P; François M; Garnier JM; Gendrel D; Guillot M; Hau I; Olivier C; Quinet B; Raymond J
Arch Pediatr; 2005 Jul; 12(7):1065-7. PubMed ID: 15913971
[No Abstract] [Full Text] [Related]
32. Adjunctive antibiotic therapy with clindamycin or linezolid in patients with group A streptococcus (GAS) meningitis.
Rezahosseini O; Roed C; Gitz Holler J; Frimodt-Møller N; Harboe ZB
Infect Dis (Lond); 2023 Oct; 55(10):751-753. PubMed ID: 37415443
[No Abstract] [Full Text] [Related]
33. Assessing the influence of the COVID-19 pandemic on the incidence, clinical presentation, and clindamycin resistance rates of
Marco DN; Canela J; Brey M; Soriano A; Pitart C; Herrera S
IJID Reg; 2024 Jun; 11():100349. PubMed ID: 38558547
[TBL] [Abstract][Full Text] [Related]
34. Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals.
Kadri SS; Lai YL; Warner S; Strich JR; Babiker A; Ricotta EE; Demirkale CY; Dekker JP; Palmore TN; Rhee C; Klompas M; Hooper DC; Powers JH; Srinivasan A; Danner RL; Adjemian J;
Lancet Infect Dis; 2021 Feb; 21(2):241-251. PubMed ID: 32916100
[TBL] [Abstract][Full Text] [Related]
35. A VLU complicated by severe group a streptococcal infection resulting in necrotising fasciitis and septic shock: a case report.
Meagher H; Corkery M; Concannon L; Kavanagh E
J Wound Care; 2014 Oct; 23(10 Suppl):S14-7. PubMed ID: 25289649
[TBL] [Abstract][Full Text] [Related]
36. [Toxic shock-like syndrome caused by streptococci--treated with clindamycin].
Nørgaard M
Ugeskr Laeger; 1997 Apr; 159(16):2396-7. PubMed ID: 9163118
[TBL] [Abstract][Full Text] [Related]
37. Invasive Group A Streptococcal Infections in Children: A Nationwide Survey in Finland.
Tapiainen T; Launonen S; Renko M; Saxen H; Salo E; Korppi M; Kainulainen L; Heiskanen-Kosma T; Lindholm L; Vuopio J; Huotari T; Rusanen J; Uhari M
Pediatr Infect Dis J; 2016 Feb; 35(2):123-8. PubMed ID: 26440814
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of clinical guidelines for the presumptive treatment of streptococcal pharyngitis in Egyptian children.
Steinhoff MC; Abd el Khalek MK; Khallaf N; Hamza HS; el Ayadi A; Orabi A; Fouad H; Kamel M
Lancet; 1997 Sep; 350(9082):918-21. PubMed ID: 9314870
[TBL] [Abstract][Full Text] [Related]
39. Group A streptococcal infections in injection drug users in Barcelona, Spain: epidemiologic, clinical, and microbiologic analysis of 3 clusters of cases from 2000 to 2003.
Sierra JM; Sánchez F; Castro P; Salvadó M; de la Red G; Libois A; Almela M; March F; Español M; Sambeat MA; Romeu J; Brugal MT; de Olalla PG; Gatell JM; Vila J; García F; Colomés JLL; Caylà JA; Coll P
Medicine (Baltimore); 2006 May; 85(3):139-146. PubMed ID: 16721256
[TBL] [Abstract][Full Text] [Related]
40. Impact of Intravenous Immunoglobulin on Survival in Necrotizing Fasciitis With Vasopressor-Dependent Shock: A Propensity Score-Matched Analysis From 130 US Hospitals.
Kadri SS; Swihart BJ; Bonne SL; Hohmann SF; Hennessy LV; Louras P; Evans HL; Rhee C; Suffredini AF; Hooper DC; Follmann DA; Bulger EM; Danner RL
Clin Infect Dis; 2017 Apr; 64(7):877-885. PubMed ID: 28034881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
